Background

Clarissa has a background in data management and epidemiology having spent five years working as a data manager for WWARN (WorldWide Antimalarial Resistance Network) based at The University of Oxford and at the National Malaria Reference Centre in Paris, France.

In 2013, Clarissa completed her Masters of Epidemiology at the London School of Tropical Hygiene and Medicine.

Now as a Research Assistant at the Burnet Institute Clarissa coordinates the Victorian HIV passive surveillance program and the Public Health Care Network of the ACCESS (The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of STIs and BBVs) project.

Positions

• Research Assistant, Burnet Institute
• Senior Data Manager, World Wide Antimalarial Resistance Network (WWARN), The University of Oxford, UK
• Scientific Analyst, WWARN, Paris, France

Qualifications

• 2008: Bachelor of Arts, The University of Melbourne
• 2008: Bachelor of Science (Honours), The University of Melbourne
• 2013: Masters of Epidemiology, London School of Hygiene and Tropical Medicine

Projects (2)

Current (1)

• ACCESS: STI and BBV surveillance system
  ACCESS is a surveillance system that collates important information on a range of STIs and BBVs.

Past (1)

• HIV/AIDS Passive Surveillance
  Carries out surveillance for HIV and AIDS in Victoria.

Publications (4)

2018 (1)

• Monitoring the Control of Sexually Transmissible Infections and Blood-Borne Viruses: Protocol for the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance (ACCESS).
  Callander D, Moreira C, El-Hayek C, Asselin J, van Gemert C, Watchirs Smith L, Nguyen L, Dimech W, Boyle DI, Donovan B, Stoové M, Hellard M, Guy R
  JMIR Res Protoc. 2018 Nov; 7(11):e11028

2015 (1)

• A systematic review of sub-microscopic Plasmodium vivax infection.
  Clarissa M Moreira, Mahmoud Abo-Shehada, Ric N Price, Chris J Drakeley
  Malar J. 2015 Sep; 14(1):360

2014 (1)

• Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P. falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine.
  Meera Venkatesan, Nahla B Gadalla, Kasia Stepniewska, Prabin Dahal, Christian Nsanzabana, Clarissa Moriera, Ric N Price, Andreas Martensson, Philip J Rosenthal, Grant Dorsey, Colin J Sutherland, Philippe Guerin, Timothy M E Davis, Didier Menard, Ishag Adam, George Ademowo, Cesar Arze, Frederick N Baliraine, Nicole Berens-Riha, Anders Bjorkman, Steffen Borrmann, Francesco Checchi, Meghna Desai Mehul Dhorda, Abdoulaye A Djimde, Badria B El-Sayed, Teferi Eshetu, Frederick Eyase, Catherine Falade, Jean-Francois Faucher, Gabrielle Froberg, Anastasia Grivoyannis, Sally Hamour, Sandrine Houze, Jacob Johnson, Erasmus Kamugisha, Simon Kariuki, Jean-Rene Kiechel, Fred Kironde, Poul-Erik Kofoed Jacques LeBras, Maja Malmberg, Leah Mwai, Billy Ngasala, Francois Nosten, Samuel L Nsobya, Alexis Nzila Mary Oguike, Sabina Dahlstrom Otienoburu, Bernhards Ogutu, Jean-Bosco Ouedraogo, Patrice Piola, Lars Rombo, Birgit Schramm, A Fabrice Some, Julie Thwing, Johan Ursing, Rina P M Wong, Ahmed Zeynudin, Issaka Zongo, Christopher V Plowe, Carol Hopkins Sibley
  Am J Trop Med Hyg. 2014 Jul; Epub ahead of print

2013 (1)

• The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data.
  WorldWide Antimalarial Resistance Network (WWARN) DP Study Group (Clarissa Moreira collaborating author)
  PLoS Med. 2013 Dec; 10(12):e1001564

News Articles (4)

2018 (2)

• ACCESS a perfect ten
• Burnet at the heart of Midsumma

2017 (2)

• Burnet excels in NHMRC funding
• U=U addressing HIV stigma